CLINICAL_TRIALS
trial_result
· 2014-03-07
Clinical Trial Update: A Study of Fortigel Testosterone Gel 2% in Males With Low Testosterone [Phase 3]
Summary
Phase 3 trial in males with low testosterone completed; results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Endo Pharmaceuticals | Conditions: Hypogonadism | Phase 3 | Status: COMPLETED | Results posted: 2014-03-07